Geode Capital Management, LLC 9 Meters Biopharma, Inc. Transaction History

Geode Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.26 - $0.64 $388,205 - $955,582	-1,493,098 Reduced 39.23%	2,312,696 $603,000
Q1 2022 May 13, 2022	SELL	$0.52 - $1.0 $30,663 - $58,968	-58,968 Reduced 1.53%	3,805,794 $2.28 Million
Q4 2021 Feb 11, 2022	BUY	$0.85 - $1.33 $204,598 - $320,136	240,704 Added 6.64%	3,864,762 $3.78 Million
Q3 2021 Nov 12, 2021	BUY	$1.03 - $1.41 $258,065 - $353,274	250,549 Added 7.43%	3,624,058 $4.71 Million
Q2 2021 Aug 13, 2021	BUY	$1.04 - $1.5 $2.15 Million - $3.1 Million	2,064,365 Added 157.69%	3,373,509 $3.71 Million
Q1 2021 May 12, 2021	BUY	$0.84 - $2.16 $423,921 - $1.09 Million	504,669 Added 62.73%	1,309,144 $1.53 Million
Q4 2020 Feb 12, 2021	BUY	$0.65 - $1.11 $280,651 - $479,266	431,772 Added 115.85%	804,475 $691,000
Q3 2020 Nov 13, 2020	BUY	$0.48 - $0.84 $113,547 - $198,707	236,557 Added 173.75%	372,703 $303,000
Q2 2020 Aug 13, 2020	BUY	$0.43 - $0.74 $58,542 - $100,748	136,146 New	136,146 $77,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.